Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-04

Clinical Trial Update: IL-33, sST2, and CRP in Panic Disorder

View source ↗

Summary

A clinical trial is investigating levels of IL-33, the sST2 receptor, and CRP in individuals with Panic Disorder. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Elazığ Mental Health and Diseases Hospital | Conditions: Panic Disorder | Status: RECRUITING